Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate for alpha-interferon induced depression.

Alvaro Camacho1, Bernardo Ng

  • 1Sun Valley Behavioral Medical Center & Imperial County Behavioral Health Department of Psychiatry, University of California, San Diego, CA, USA. aamacho@ucsd.edu

Journal of Psychopharmacology (Oxford, England)
|March 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinicians' Preferences and Attitudes Toward the Use of Lithium in the Treatment of Bipolar Disorders in Mexico.

Neuropsychobiology·2026
Same author

Report from the WPA Section on Positive Psychiatry 2015-2025.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2026
Same author

Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025
Same author

Breaking the glass ceiling: women's scientific participation in the 24th World Congress of Psychiatry.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2025
Same author

Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry·2024
Same author

Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2024
Same journal

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Effects of pimavanserin, xanomeline and highly-purified plant-derived cannabidiol on MK-801-induced behaviours in mice relevant to psychosis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Pharmacokinetics and pharmacodynamics of orally administered S-ketamine in healthy participants.

Journal of psychopharmacology (Oxford, England)·2026
See all related articles

Interferon-Alpha therapy can cause severe depression. A melanoma patient rapidly improved from this depression using methylphenidate, a psycho-stimulant.

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Interferon-Alpha (IFN) is a standard treatment for chronic viral infections and cancers like melanoma.
  • IFN therapy is associated with a significant risk of severe depression.
  • Existing literature suggests antidepressants can manage IFN-induced depression.

Observation:

  • A case study involving a melanoma patient treated with IFN is presented.
  • The patient developed severe and prolonged depression during IFN therapy.
  • The Hamilton Depressive Rating Scale was used to assess depression severity.

Findings:

  • The patient experienced a rapid and significant improvement in depressive symptoms after receiving methylphenidate.
  • Methylphenidate specifically targeted and alleviated the neurovegetative symptoms of major depression.

Related Experiment Videos

  • This suggests methylphenidate's efficacy in treating IFN-induced depression.

    • Implications:

    • Methylphenidate may be an effective treatment option for severe depression induced by IFN therapy.
    • Norepinephrine reuptake inhibitors or psychostimulants could be beneficial for managing IFN-associated depression.
    • Further clinical research is warranted to explore psychostimulants for IFN-induced depression.